Human HTN3 adenoviral particles

The HTN3 gene encodes histatin 3, a small salivary protein predominantly expressed in the parotid and submandibular glands. Histatins, particularly histatin 3 and its proteolytic product histatin 5, play critical roles in innate immune defense within the oral cavity, exhibiting potent antifungal, antibacterial, and wound-healing properties. The HTN3 gene is part of a family of histatin genes located on chromosome 4q13.3 in humans. Histatin 3 is characterized by its high histidine content, which contributes to its metal-binding capacity and antimicrobial activity. The HTN3 gene can be used for therapeutic research in oral infections such as candidiasis and to promote mucosal repair.

Human HTN3 adenoviral particles are recombinant adenoviral vectors designed to deliver the HTN3 gene to target cells for research or therapeutic purposes. Adenoviral vectors are widely used in gene therapy due to their high transduction efficiency, ability to infect both dividing and non-dividing cells, and ability to carry large amounts of transgenes. These particles are generated by replacing the pathogenic gene of the adenovirus with the HTN3 coding sequence, ensuring safe and efficient gene delivery. The resulting HTN3 adenoviral particles can be utilized to study histatin 3’s functional mechanisms, modulate its expression in vitro or in vivo, and explore its therapeutic potential in conditions such as oral infections or tissue regeneration. Additionally, they serve as valuable tools for vaccine development or immunomodulation studies.